BioLattice
Revolutionizing Tissue Repair
* Data source: Crunchbase
- Founded
- 2014
- Employees*
- 2-10
- Funding to Date*
- $729,000
- Website
- biolatticetech.com
“We’re developing alternatives to donated tissues and organs. So many people either have low quality of life or unnecessarily short lives because the system in place just doesn't work for everyone. So, I want to do something in my career that fixes this altogether.”
Worldwide, there’s only one donor cornea for every 70 people who need a corneal transplant to restore their vision.
BioLattice Ophthalmics, Inc. is addressing the need for tissue repair solutions, beginning with cornea.
One in 70 patients who need cornea tissue obtain it. Globally 2 million per year suffer from corneal blindness while only 200,000 per year receive vision restoration via cornea transplant.
Almost 13 million globally are on a donor cornea tissue waiting list. There is currently no standard of care alternative to donor cornea tissue for full thickness cornea transplant material.
Our engineered cornea will be a true alternative to donor cornea while also offering corrective vision.
More Companies
